Thyroid ElderlyÑD®ÑD®TEXtREAdxBo€ˆBo€ Bo€üBo€ËBo€3…THYROIDÄISEASEÉNÔHEÅLDERLY **CHANGES€ã{PHYSIOLOGY×ITHÁGING DecreasedÔ4ðroduction‚9€ß€Øclearance ->Îormal‘levelsw‚I‚7ïfÔ3äueôoäeripher‚ conversm4I˜(whichîƒJlyáccountsæor 80%‚Ô…).Óomeƒ‘thisåffectíayâe„non-thyroid…øillness (NTI,åu€Ôóickóyndr‚ˆ)én „kthe 5'-deiodin‰ „°tivity ƒˆ†ö.‰Slight…ȇ¯ˆH‰s. Šïe‚ùradio‚ªeõptakeLŠã†’…¢-binƒÐgçlobul„Èand€ï€ìpŽ€lbum€ùreŠƒ¢TSHòesponsive‡â‹qRH††(ImplicaI‹“usƒ¹P-stimul€Úôe€png)†Š**HyŽÀŠüism”QEpidemiology 15Âp‚ÈeŽawitбŒ€toxicosÀ…™oáge 60.Ðrevale“Ñ’phƒ'ƒ"”˜ges 0.5“2.3%.Çraves' „(‹…˜llíost“pmm–ècause,âut”ÀƒÐ †˜†P—èlarçoit„ Šá€òsolitar”0denoma‚`ŠÈ‚dthan‘!y•g…Àpeople. ‡úxc“ ŽÜ’Hfood,íedŠõ, –€˜ tra„ø•qalsoŽ!cipƒ¨t™Ð‰‰•Hsp€è˜²”ØŠoŠi†e“C‘Ž(lÍanifXŽ„ Ve†X…õƒbsŒxátyply,çðœð›È"fewŒ‹âk•(tic,ˆ`r)g‰ð&ˆ‹subtl‹xymptomsˆM‹§ž ƒMºwe™ ìoœ–1car˜(vascŒ"m…§•p™’M‹¯œ¡elder Ð Atrˆpæibrž”Ó Tachy‚¢a < 100 (A.!‹SR)¸ngž(åxacerb¼Co’yž¨eè§€tæailure/dyspnea˜–©)Mark©Ø†osÛOfteŒÀ¡èp˜ñ –u™£¦(gh¤(nš al)¥@¡ˆn«y.]„á“x…Ø A™hhŒˆle“@rš)Ost“or™r&âo¡¨fr¤P…8¬HDemšàia,ªÑfÀ®c‰ï•o•iœ] G—«‰Ï‰È>‰É,€l”Z‘óSwe È¤( H€H¨ðtol®P°Ñ Diarr‰È WŽÿ—tgaªh Polyphag‡Nervous¬A,ôrešÐ‚È¢Iªâe¥€flex†ÑL¬Ølag (“ ˆ°”9žá¤}Ž ‰„€Ò¡W¤s(occurrŒ’l jexcl¦È¶šR’Œ):ËX®Øµ(z¸Àb²l³à¹a²«´de™¹µ¹,ólowº‹Á¨Ãž›‹ë™Hbšø¥÷š¤ˆt¶`²(¸¨hap²H¹uƒƒ±uto£¸¥8fun·l —¿—¿ ‡£€n 9-22%µÙªÿ«Ç¶Ÿ ¨#¼¦²frequ¬ðˆ§›)¿pe­Ç(25-35%»˜Åœ4®7®ÿh¬8áè¸P®€inc°`®= 3õU/mv¼ b¾¶8¹â‹Ð,Òd¿ÀŸ/Ÿ+¤ˆan½@ge (   ‰e©0Ž)·°p¼¯X£é” RAIU (ra´P½¤uptake­Š ”xb°É†#ŠS ¥8m¦àˆ¿Y1/3—Rµ<¼úGr˜˜s' ¤ˆ‡’·É2C¾G‹ï¦Ð²¾™¸g­ ,è£hˆØ©phœš­°£f„M…I‹1ƒ!³ùuisƒÇf´¨ŽÏ‚¿r½`Also³@ow ˆ2²ègˆk-induc·xªßªÚ{Ž t—Ú T„È®X€|§¸choi°øµ€Šß‹p)”„th¶hg»¸§øefin›c­€˜ av—Ù‡zriskªA›8µð¸¸Š ˆA¥E´ct‚‰§½¹Bpoo®Ø.Ћ7‹7‹7‹5z¨Ii¹°‹è’xdo‘ɽèrep·Á€„f‰q­£ª´±ºƒ™õ¯Ø’„‘un ¸n ri¬±šs°ˆpe¢b­ÊeŸø‘«9¶Ú¤¾renµX½íåu§U¤:a¿ø§Þ¢¾¤0f¯¹Àrap‰Ø¸¨µ(¾P³x£÷œÐ„eek…˜˜¯8‡)˜Iª¨im´úwork”!u½À‰ssu€Ðƒïƒï¸1-2‚²sº¯‚²Uªðbeta-blockeµÈ…©0mpt•8„éroµ¡8¦qed¦Ðu½¸£øi¹Ñreg˜É½è¹p¾-Œa¿Ào¿¿“¿É²)¡•ËŠÅ¢?¢;§(²u‹2„Fm…Xµ´¾Xƒ ‘A­¿¡de¦c¶zAŒOärug‡è»»2like•zæai¡z»U¦—¦“(¹ù¥hlap´h–àeáfteräiscontinuation)ándôhereésáèig€hãhanceïfádverseåffects (e.g.állergicòeac‚Is, @yòarelyágranulocytosisƒ;problems÷ithãompliƒ9. **HYPOTHYROIDISM € Epidemiology Vƒ°monén…©ålderly,‚“prevale…Ƀðging 0.5ôo 7%. Most‚cau† ‡‘utoimmuneˆ0yroiditˆH(Hashimoto's‰¡ease)ƒ8hichèa‰P„!c‡ðse†ÉƒÍƒ8…ÉHypo‚}smŠÑmo‹… t†hospitaliz‚Œp€ÀŠ0ƒtP€†women;Zless‚GˆA‹ˆ„€Piodine-defic‚hcy„jOŽé‡¿‡¸s:éatrogenŽ(pˆ¹tŽ@tƒ(tæorèyper†‡ÈexcƒÉƒæromärugƒÀ‚ántrastŽ:Cli‚°alíanifest“:s„@“ønï’hlook‰¨ƒIse’èhŠA’ .Óympto‘mayâeáttribut‹(Ž8-exis•øgŒµ„àspeci”ðhro†©”. ŒOŒJ‚±also‚Ùm‚@ak„ Žpsƒ½—‰‘Ê—;f™(guƒ cold“¨to—¸˜Ñ,‡øyókin€án„Žš€“@ItƒGƒC‘!du“o•Ès“ounset›úslow˜égrŽèœ¨Š©atypŠBfŒÈu€È.Ía„€ 4˜ dexsu’PcžpšJ“營‡œ„$non-›÷Ÿ)replace  iapš Hinadeq¡Xào (_‘aÂSigŽø†:Š/’˜m…*+ƒè–øÿù: Macr¡i¢anŸ˜a (”@norm€³)š oa¤@n˜ Per“(rd‚‰•€pleu’9¥ uŠ Cong“èiveèear–¸ailŠ8 (‹ ’˜¥ €Ø‚omyo›øhyƒ!—Êe oŽÈbradyƒ; Deafƒé,‚Š¢álo„YC©Øbella¡axia¨J‘¸o˜harp˜Xtunnel“(nd™È•šðip‹9ˆx…Ѓû†°sychœÙic:š±†k“XŒÊ‚Ñde§ ‘",érr¡øbilit¨pá«Y We® t„úƒXo’ippet¢¹‡ H¢8°p–p‹X†Ÿ‚riglycŠÐ«¡‡I§§A±˜¦¥©ho—¸¨€¤`vel¯ÈŠ Ž8e§@yˆÔNas @³pŒRŒ±Sleep„pneŠˆA£†hi§)€aalg‹IMyxe¯°a± 8¯«¨Ža´ó—ˆcepti‡ëà…_‘s®vˆ¨¯É¬ð·@0med¤¸¤dDe­ÕvŠÉlat…±dr‘y´XDiagnŠcAsõsual,ÔSH¡Ps¤¸¹@³ám²yƒ}–™ƒ ©ð”‰rima¸p˜?°A’utÔ4‰Ìíu´ˆ¤~³Ÿ@d“¸e´óƒ‘¨<«¡À±ÈºØe‹¸œˆ¤y¸"recª±yŒèŒ©½˜Ÿ¶l¬Hill™©¸»0Un¯”€ž¹¹a†ºŽB«•blun«yby‚G‚G˜f¯`ºà¡ Š¿¹ dš@m´,çlucocƒPicº”9heny»Pnº(how¯¹–¾*¼@cºðs‹¼‹‚®`¡H¦Ðp—Їr¾@¿¡ ©±™¿»}A£‚e˜¶£ºp–ð³pf£:¾Ì«õlµYouº¨help¶dšÙf°¸u„ømmu¶ø½Õtis¶¢T¸î L-T¾¹x¸1shou°°µ0º¨½(–`¦²go¤±Œ9…Iizµi‹>ŒAT— óimu“ȇÀ†Œ—fun¥½x¾À†d¿¹f£p Y·is–1‚ ’²9¸ows¢ïl¡È½ŠŠò¹ø‡regƒº¬amˆPt·©T3¤P›¸Â¬Ùbody.Á¹`¿éŠÁµ¡8£err¾°¿(»(±`idl©èabsorb– which¾¶¨du³a§˜ak“L¤™½`ºc“\an°mé—Q¶bD¹«˜¸‚0d™Ùcl®x¼†«`ag´ôrµXiš — ¶Ÿ¶˜¨°110õg/™¶¢½(13€Ï´¡yèg¾9Thu¯h޲adv¿¨¯¡ƒ`¿Øƒk†Ð¦º$nec½øŸ°‰ˆ·l‡2… “ê°°-t’U’Ç… in¥¸žÂŸð©xus ‚WéfˆÝ¨`s±ron£!¶ðŸñ¿h­iŸ8St·‰”z12.5-25‡ÒÈo‘žãi®é¿½zG‰œéy 4-8÷eek·ˆ ˆilœý–µed.Ét¥ Q¦p¸€ibl’fuž ¤ðt¿bžòf¾ðg±èª!s )e› R·mb®Èthat¦a©ø¯ˆ­÷©°¬´Ü°ø.g.«àsuli¹Q»¸œà´˜orph¤_¤_ŽÑ–³Œ¿Œ»¾™sˆ¸¡„0«Ñ»`¡ˆ«Id±–bo¸@¡¨³0y¯Yex“0rb²Ú«é¢ØµŸ©h•XtŒÍ (‡Ü¼€MI§éºõLV¯8½aƒ˜¡”E˜¯És¸ a  rª—¨ ±Ðt0n¸˜b»(t‘Ñ¡À¦øµ€-©ý¸ ™bT4¦ª**NODULARÔHYROIDÄISEASE W—¢@¯ ªd®°£9´øom­xŒ$°P­jd¦p® ¤I¸ñ“ªÙŽ+§P±¨øi¬èŽ´ÈAbo¸À90%µéw‚è­Ð¿±yn 70¦ò6€û€ê·xœQ 80ˆ³¯ „2‚‘΃o°Ps™(e桺#¯ino§ð€Ð°X»1evol‚YoŠYc’p§ ¾aºé›˜yªÀ¾_°ÂA³0mpšªµSçŒð°H‡·‡·—º°­pŒÇ¬Bªžø–Ьðìik¼Ø­y§PŠ`o  °r¶Ì¾²t³øcos¹XŒXa³à¤±‡îôeŒo¾a‡? &îon-suppressible. Olderðatients÷ithíultinodularçoitareío€(suscept‚ ôoéodine-inducedôhyrotoxicosis,æoråxample,áf‚Qreceivingòadiocontrast Pam‚xaron„ã**THYROIDÃANCER Papil„°yãarc… maïccurs„ëfrequ†Hlyäurƒ!th…8hirdándæif‡decade„ð€šollic‡Zcancˆieaksénâlat‚¸¿e. Un†¸tun€Øly,åvebse÷ell-differŠxiàˆœid‚ôsŠWaggŒZve (ŠÚr†ðŠu‹@çrowth,íetˆèaŠj‰Ður‚ÈcàŠZsurgery)…meŽi‡àŽ2an† creasŒÀØtality (especial‰ ‡ males)†¨Thuˆ‘æull†˜alu o‚ ˆYdic†bŽyanyîew’x‘e¹ƒ=‰¡siz€ f‚H“@-exis’Xgl.ÏŒ€ŒXlag‹1cludeèoarsen”Ð,äysphagia,”Àin‘Àd¨‡º‚ÈŠ}“ànearbyótructu–¸, Žv…`lìym‚(deno–àh0ùaö‰x0rmŒ½˜*T‰çálsoèaŒ¨Š–Ȉ"„%anapl• icŽ÷”†(almo–€ex†ØŽñ”hse‘’›Fo„He 65,•"švirŠ˜nt‘¦neoƒIm, ˜ ù‡€ŽW >= 85%)–Ê“-s˜¸˜¨“0—pˆ"™ŽöFNAóhouldâeä‚¡be‡ay‚'’³’¯’«Ÿh„ñïu…—q•R¡ hic“x¡t“p—™Œ¨žá’ ›ÁchemoÙap™ˆnot•ݤ"M” ¤ˆß0£²at¤ør‹`¤zrisk?‹Ça‹‰¼”Ús¢,OTH¡àPROBLEMS N¨@œ¬‘H¢€“¹—Aqu§X•Á—ðŒ1š·š±ŸÈ…Hnutri˜É,¡fec™!§@maj§Pœ„•ÀooœA¦â£¨Èˆpbet£© Ð•fail•˜,èe«écsY–ebrovas¤³€Îh—xtÏÐign¥˜¤ªu¨X‰zssožø£Ñ ;l­ø¤?Ÿn…ª „hts¦pDepeŸ¬€€©©xs¦ˆ‡ yž9ˆô•! Hmay‘É–r“ lowÔ3Žr¢8°q€’4†¨ighò€ç€å°ql¢è¨ÁTSH´E¥¬˜ç±8‘¸’ak±Am£™me¤*‹{—›«‘„™ša«¨ctá P„a‡w‡s¥:¶H¬Ñ·3ˆˆˆŠFµ§, © hium‡Úcau¯ hyp–X®¢ism;µ¯„k//¶á¸×¸Ñ;¹Ì³9¸ƒ'ƒ'ÿºÏùd¦Àm»Ð Ðc›¸otid»glucº™q³˜s¶‘·q¬ó‹ˆ¤H°®Á;»€©8 rogen¤…am½Ðf¶pÁ‡s²TBG (²”ºÒo²pâ ˆž™»èƒ(4)½âSubclin¬b‰—ˆj(SH‘öT3/à:ɵ¦œM¯Ãup¯™15%ªGªGªC¡?¸!omen½hR¾’¡´€o»ƒ—áo¬tŽoCran¬ 4%ƒZ8%,ºS–q™h£ã€—rŠ’–xels (>10íU/L¬ƒp(t¾Ñanti£u€jbÀ„ˆ(½à40-67%¹¹¾¾sŠ'“·“´ÿnˆ¨-20ú¾°¶N³e¾éHashi¬o'sº ¦(§ªµb± m¿`— ±q®A‰ø¨’ ¦*¹Èsial,r¾Ø½h¼ƒ¬Šf›¸°X¦pypº0ip”pmi¸`°’ž#y¡¿è‘Ãcho­¤Øol±y6-17%)½3s½Øtoms© v™É„m.¶0¤)uºèµøbal§è¼ØagainŒý°Ù…ö(CAD‡ùAd™Xi—X´“¦Á›ó(e.g.œ®˜œ©¶cou¦£ª8)§Ú°Ðc†Øt· ‘ÿ gm—Ï—Ï“( ?(œe—ß—ß:З»à»Å2%–1·¼–/–/ƒ?£t¶X¬Ù(2-10%)•Œi˜8»Cè®auto¹àous¿°Ížâ•deºâ(˜˜ŽÈù´)®1mulޏ»9¼ go¹Àr (9-3”8”‰-7Z“âAóµ@if­ðº p¤éŒ#c·xs„@™0²iz¥a­3im”‘C«Ú°À¦¨³@´)£Çr‚(s'º%½Éªû-sufƒÈ‡Š¸è‡™±Ð…Ç…Âw’8‡‚¿¨Stu’…Jshow·á»#¿á»3»u”ab°9‰¨Ÿðy®áºradiuƒÓfem«ºneck¨@sp’ˆ ·èœ0¥€®¨usºX¥ê¢Sa 3.8-fold¬g¬±¯€¨ÔatrœÐæibr½x—ƒÜ¢sequžQ°8Žp¦”tho¹à¸:''"Žò©Øa‘ö¨Œa¼³pœÔ‘{‚~Ÿø¶ø¾t¾˜de¡Q—| (»ºT3±Ð¸4òƒdïutŸØŸ¾¯h™Ï»*·(r‰‰·À¡ðope³¯c´"¿P¶Œ place¦BŒ@rapy´ÚREFERENCES µHB±¨uskaÄG§Ñ­T’Wެ¼ªQospH§€ 1991;26:85›@2·°Chio¶ÈoÌ,ÍariottiÓ,к(„Áƒ•e¬ ƒƒBailùèÅndocr·€Metabƒ‰7;11:25›0»8FeitÈ…¿ž&…Ç…ÅClinÇeriatrÍed 1988;4:151-61. FelicettaÊV. Thyroidäisease ðtheålderlySpecialæeatures,ãhangesYmanagement‚XPostgradƒ¿83ƒÀ3-60ƒÀLevyÅGƒŸƒŸƒŸƒ›…¹Cl†@NorthÁm†(91;75†37†0SamuelsÍH…ubcxic…8t†‡†‡†‡‡‚˜…:803-13ˆÀ T‡Àaboveòeviewésáóynˆˆs€`ofˆÚpapersìistŠø‰„referencˆ¸sectionŠàEveryåff†8èasâee‰¡deôoånsŠ€áccuracy,âutÉŠ˜keîo÷arranty„hgardingårroƒÐandïmissƒ0€sassum²p€°ibiliàor…@a€l„8ìos†HräamÈyult‚áfromÒin…xma†ãontain’0withi† Fáe€¨l‡â_ˆ+†Øróhouldˆ›‡I’originextŠU‰¯.Õ“à‹ Œ#„Gn…Òp„˜“@ãa‰¨purpos”!säonÀt•º–0cre…âtËianPl—*em† ‰†¹Š€y‡Pm–1ˆâsug–øŽ!s™€MarkÇoodarzi,Í.Dš(mg€Œ@mednet.ucla.edu ’@<**>